Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glazi M 80mg/500mg Tablet

Prescription Icon
Prescription Required

Marketer

Trio Pharmaceuticals Pvt Ltd

Salt Composition

Gliclazide (80mg) + Metformin (500mg)

Overview Glazi M 80mg/500mg Tablet

Metformin/Glibenclamide 80mg/500mg tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continue taking this medication as prescribed, even if feeling well or experiencing controlled glucose levels. Discontinuing treatment without consulting your doctor can lead to elevated blood sugar, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. This medicine is one component of a comprehensive diabetes management plan encompassing a balanced diet, regular exercise, and weight management, as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Common adverse effects include hypoglycemia (low blood sugar), characterized by sweating, dizziness, headache, and tremors; constipation; and vomiting. Carry a quick-acting glucose source (e.g., sugary snacks, fruit juice) to counteract hypoglycemia, maintaining regular meals. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects are altered taste perception, nausea, diarrhea, abdominal pain, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Inform your physician of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or lactating individuals should seek medical counsel prior to use. Regular blood glucose monitoring is essential, and your doctor might recommend blood tests to assess blood cell counts and liver function.

Uses of Glazi M 80mg/500mg Tablet

Diabetes mellitus type 2

Major Benefits of Glazi M 80mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the Glazi M 80mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

Common Side effects of Glazi M 80mg/500mg Tablet:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Dizziness
  • Diarrhea
  • Upper respiratory tract infection
  • Nausea
  • Flatulence
  • Constipation

How to use Glazi M 80mg/500mg Tablet:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the Glazi M 80mg/500mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with food.

How Glazi M 80mg/500mg Tablet works:

Each Glazi M 80mg/500mg tablet contains gliclazide and metformin, two medications used to manage blood sugar levels.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Alcohol and Glazi M 80mg/500mg tablets should not be taken together due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Glazi M 80mg/500mg tablets during pregnancy poses a confirmed risk to the fetus and is therefore inadvisable. Exceptions may exist in critical medical emergencies where the potential benefits outweigh the known hazards, as determined by a physician. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Glazi M 80mg/500mg tablets while breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glazi M 80mg/500mg tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glazi M 80mg/500mg tablets. Physician consultation is recommended. Regular kidney function monitoring is advised during treatment.

LiverLiverCAUTION

Exercise caution when prescribing the 80mg/500mg Glazi M tablet to individuals with hepatic impairment; dosage modification may be necessary. A physician's consultation is recommended. In patients exhibiting mild to moderate liver dysfunction, initiate treatment with a low dose of the 80mg/500mg Glazi M tablet; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Glazi M 80mg/500mg Tablet :

Should you forget a Glazi M 80mg/500mg Tablet dose, take it immediately if you remember. Otherwise, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glazi M 80mg/500mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glazi M 80mg/500mg Tablet

Glazi M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glazi M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glazi M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Glazi M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-Associated Lactic Acidosis or MALA). This rare side effect is more likely in patients with kidney disease, older adults, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glazi M 80mg/500mg and seek immediate medical attention.
Prolonged Glazi M 80mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its stomach absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, supplemental vitamin B12 intake at least annually is recommended by some researchers.
Glazi M 80mg/500mg Tablets are contraindicated in patients with allergies to any ingredient or excipient, and in those with moderate-to-severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Combining Glazi M 80mg/500mg tablets with alcohol is unsafe. Alcohol can worsen low blood sugar and raise the risk of lactic acidosis.
Glazi M 80mg/500mg tablets combine gliclazide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with a healthy diet and exercise. Gliclazide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for treating type 1 diabetes.
Glazi M 80mg/500mg tablets may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Glazi M 80mg/500mg Tablets can cause low blood sugar (hypoglycemia), characterized by nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and anxiety or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry glucose tablets, honey, or fruit juice for emergencies.
Glazi M 80mg/500mg Tablets can cause lactic acidosis, a serious medical emergency (also known as MALA, or Metformin-associated lactic acidosis) resulting from excessive blood lactic acid. This rare side effect is preventable by avoiding use in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these symptoms, discontinue Glazi M 80mg/500mg and seek immediate medical attention.
Prolonged Glazi M 80mg/500mg Tablet use can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left unaddressed, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glazi M 80mg/500mg Tablets are contraindicated in patients with known allergies to any ingredient or excipient. They should also not be used by those with moderate to severe kidney disease or metabolic acidosis, including diabetic ketoacidosis.
Consuming alcohol with Glazi M 80mg/500mg tablets is unsafe. This combination can worsen low blood sugar and raise the risk of lactic acidosis.
Glazi M 80mg/500mg Tablet
45
MRP 52
13% off